Coronavirus (COVID-19) Nucleocapsid Antibody
Artikelnummer:
ABI-11-2003
- Bilder (3)
| Artikelname: | Coronavirus (COVID-19) Nucleocapsid Antibody |
| Artikelnummer: | ABI-11-2003 |
| Hersteller Artikelnummer: | 11-2003 |
| Alternativnummer: | ABI-11-2003-100UG |
| Hersteller: | Abeomics |
| Wirt: | Rabbit |
| Kategorie: | Antikörper |
| Applikation: | ELISA, WB |
| Immunogen: | A partial length recombinant coronavirus Nucleocapsid protein (amino acids 250-410) was used as the immunogen for this antibody. |
| Alternative Synonym: | covid-19 |
| The structural nucleocapsid (N) protein of nCoV/SARS-CoV-2/COVID-19 is a predicted 46 kDa phosphoprotein having 419 amino acid residues. A short Serine rich stretch and a recognized nuclear localization signal are the unique features of the nucleocapsid protein of nCoV/SARS-CoV-2/COVID-19, which seems to have a little homology with the proteins of other members of this large corona virus family. These features also suggest the involvement of nucleocapsid protein of nCoV/SARS-CoV-2/COVID-19 in different stages of viral lifecycle. The protein has multifaceted activities including packing of the nCoV/SARS-CoV-2/COVID-19 viral genome into a helical ribonucleocapsid (RNP) and playing an important role in viral self-assembly causing nCoV/SARS-CoV-2/COVID-19. The nucleocapsid protein of nCoV/SARS-CoV-2/COVID-19 also forms dimer in the cell by self-association with the help of interactive C terminal domain. |
| Klonalität: | Polyclonal |
| Reinheit: | Protein A Chromatography |
| Formulierung: | Purified |
| Target-Kategorie: | coronavirus Nucleocapsid protein |
| Application Verdünnung: | Recommended dilutions: WB: 0.5-1 µg/ml. However, this need to be optimized based on the research applications. |
|
|
Figure-1: Wells of a 96-microtiter plate were coated with 4ug/ml of SARS-Cov-2/nCov/COVID-19 Nucleocapsid recombinant protein (21-1003). The binding was detected by addition of different dilution of 11-2003 polyclonal antibody. The reactivity was detected by a HRP-conjugated goat-anti-rabbit polyclonal antibody. |
|
|
Figure-2: Western Blot analysis of SARS-CoV-2 Nucleocapsid Protein: Anti- SARS-CoV-2 Nucleocapsid Protein (11-2003) was used at 2 µg/ml on (1) SARS-CoV-2 virus infected Vero Cell lysate and (2) Mock infected lysate. |
|
|
Figure-3: Western Blot analysis of Nucleocapsid antibody: Anti- Nucleocapsid antibody (SARS-CoV-2) was used at 4 µg/ml on recombinant Nucleocapsid Protein (21-1003). |
Produktgarantie und fachkundiger Support
